Aulkemeyer P - Search Results

1

CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial.

Wollinsky KH, Hülser PJ, Brinkmeier H, Aulkemeyer P, Bössenecker W, Huber-Hartmann KH, Rohrbach P, Schreiber H, Weber F, Kron M, Büchele G, Mehrkens HH, Ludolph AC, Rüdel R. Wollinsky KH, et al. Among authors: aulkemeyer p. Neurology. 2001 Sep 11;57(5):774-80. doi: 10.1212/wnl.57.5.774. Neurology. 2001. PMID: 11552002 Clinical Trial.

2

A small sodium channel blocking factor in the cerebrospinal fluid is preferentially found in Guillain-Barré syndrome: a combined cell physiological and HPLC study.

Weber F, Brinkmeier H, Aulkemeyer P, Wollinsky KH, Rüdel R. Weber F, et al. Among authors: aulkemeyer p. J Neurol. 1999 Oct;246(10):955-60. doi: 10.1007/s004150050490. J Neurol. 1999. PMID: 10552246

3

The human endogenous local anesthetic-like factor (ELLF) is functionally neutralized by serum albumin.

Aulkemeyer P, Brinkmeier H, Wollinsky KH, Rüdel R. Aulkemeyer P, et al. Neurosci Lett. 1996 Sep 20;216(1):37-40. doi: 10.1016/0304-3940(96)12997-9. Neurosci Lett. 1996. PMID: 8892386

4

The small sodium-channel blocking factor in the cerebrospinal fluid of multiple sclerosis patients is probably an oligopeptide.

Aulkemeyer P, Hausner G, Brinkmeier H, Weber F, Würz A, Heidenreich F, Rüdel R. Aulkemeyer P, et al. J Neurol Sci. 2000 Jan 1;172(1):49-54. doi: 10.1016/s0022-510x(99)00285-3. J Neurol Sci. 2000. PMID: 10620660

5

An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system.

Brinkmeier H, Aulkemeyer P, Wollinsky KH, Rüdel R. Brinkmeier H, et al. Among authors: aulkemeyer p. Nat Med. 2000 Jul;6(7):808-11. doi: 10.1038/77543. Nat Med. 2000. PMID: 10888931

6

Anti-GM1 antibodies can block neuronal voltage-gated sodium channels.

Weber F, Rüdel R, Aulkemeyer P, Brinkmeier H. Weber F, et al. Among authors: aulkemeyer p. Muscle Nerve. 2000 Sep;23(9):1414-20. doi: 10.1002/1097-4598(200009)23:9<1414::aid-mus13>3.0.co;2-0. Muscle Nerve. 2000. PMID: 10951445

7

Borna disease virus-related therapy-resistant depression improved after cerebrospinal fluid filtration.

Bechter K, Herzog S, Schreiner V, Brinkmeier H, Aulkemeyer P, Weber F, Wollinsky KH, Schüttler R. Bechter K, et al. Among authors: aulkemeyer p. J Psychiatr Res. 2000 Nov-Dec;34(6):393-6. doi: 10.1016/s0022-3956(00)00033-9. J Psychiatr Res. 2000. PMID: 11165306 No abstract available.

8

[CSF Filtration as Experimental Therapy in Therapyresistant Psychoses in Borna Disease Virus-Seropositive Patients].

Bechter K, Schreiner V, Herzog S, Breitinger N, Wollinsky KH, Brinkmeier H, Aulkemeyer P, Weber F, Schüttler R. Bechter K, et al. Among authors: aulkemeyer p. Psychiatr Prax. 2003 May;30(Suppl 2):216-220. doi: 10.1055/s-2003-39747. Psychiatr Prax. 2003. PMID: 13130379 German.

9

[Cerebrospinal fluid filtration as experimental therapy in therapy refractory psychoses in Borna disease virus seropositive patients. Therapeutic effects, findings].

Bechter K, Schreiner V, Herzog S, Breitinger N, Wollinsky KH, Brinkmeier H, Aulkemeyer P, Weber F, Schüttler R. Bechter K, et al. Among authors: aulkemeyer p. Psychiatr Prax. 2003 May;30 Suppl 2:S216-20. Psychiatr Prax. 2003. PMID: 14509081 German.

10

The pentapeptide QYNAD does not block voltage-gated sodium channels.

Brinkmeier H, Weber F, Aulkemeyer P, Wollinsky KH, Rüdel R. Brinkmeier H, et al. Among authors: aulkemeyer p. Neurology. 2003 Jun 10;60(11):1871; author reply 1871-2. doi: 10.1212/wnl.60.11.1871-a. Neurology. 2003. PMID: 12796562 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters